Report

The North America Ampoules Packaging Market size is worth USD 3.30 Billion in 2025, growing at an 5.29% CAGR and is forecast to hit USD 4.26 Billion by 2030.

Key Highlights
- The demand for ampoule packaging is expected to grow as the pharmaceutical industry in North America is growing significantly in terms of innovation and competitiveness despite its mature status compared to other areas. A rise in environmental concerns and increasing spending on healthcare infrastructure has sparked the development and innovation of eco-friendly packing solutions.
- The growth in patients with acute and chronic illnesses has directly and positively impacted the demand for ampoule packaging. The market is expected to grow due to the rise in demand for sterile, tamper-proof, and non-reactive items with excellent performance.
- Canada's surging demand for injectable pharmaceuticals is significantly boosting the market's growth. The strong demand for oncology treatments and other high-potency drugs, like antibody conjugates, steroids, and IV fluids that necessitate a rapid onset of action, is anticipated to be the primary growth catalyst.
- The rising demand for sterile medical packaging products from pharmaceutical industries is set to propel the growth of the market during the forecast period. StatCan projects that in 2024, the revenue from Canada's pharmaceutical and medicine manufacturing industry will reach USD 9.94 billion.
- Historically, manufacturers have relied on glass to produce ampoules. However, with the widespread availability and cost-effectiveness of plastic, its adoption has surged, significantly driving down ampoule costs. This affordability stands out as a key advantage of plastic ampoules compared to their counterparts. Consumers increasingly favor unit-dose parenteral packaging over multi-dose alternatives. In the United States, data from the Food and Drug Administration (FDA) indicates that unit-dose plastic ampoules constitute nearly 24% of the pharmaceutical packaging market. Furthermore, they are poised to outpace others in terms of value, presenting above-average growth prospects.
- However, concerns over ampoule dumping are hindering the expansion of the market. Given that plastics are not easily decomposed, they pose significant environmental challenges. The rising use of sustainable materials, like green or biodegradable plastics, in ampoule production bodes well for the market's growth.
- Stringent legislation aimed at enhancing the integrity and quality of domestically produced pharmaceuticals has led to increased use of glass in pharmaceutical packaging. The rising demand for sterile medical packaging in the pharmaceutical industry is projected to drive market growth during the forecast period.


North America Ampoules Packaging Market Trends

The Pharmaceutical End-user Industry is Expected to Record Growth


- The growing pharmaceutical end-user industry drives the ampoule market. The introduction of injectable therapies through the development of biotechnology is driving the growth of the segment. The segment is also expected to grow due to the development of biotechnologies and their applications in the region, along with increasing demand for ampoules with advanced technologies like RFID tags to protect against potential threats and costs of drug counterfeiting.
- The increasing manufacturing and research activities are raising the demand for regulations to ensure drug safety and protection. Hence, manufacturers are collaborating with contract packagers to develop drug adherence packages that communicate dosage information through print and graphics.
- According to the IQVIA report in February 2024, North America's pharmaceutical sales are expected to reach approximately USD 992 billion by 2027, solidifying its position as the leading regional market in global pharma sales.
- Pharmaceutical sales are growing in the region and are directly contributing to the demand for packaging formats like ampoules. According to a February 2024 report by IQVIA, the United States maintained its position as the world's largest pharmaceutical market in 2023, raking in over USD 670 billion in revenue. Such trends are expected to contribute to market growth in the future.
- Furthermore, consumers are increasingly opting for unit-dose parenteral packaging instead of multi-dose alternatives. Plastic ampoules, offering fixed dosages, enable pharmaceutical companies to manage costs more effectively by minimizing drug overfill and streamlining production processes. As a result, plastic ampoules are particularly beneficial for pharmaceutical firms handling high-value medications.


The United States Expected to Dominate the Market


- The United States stands as the leading global market for packaging, particularly in terms of glass ampoules for the pharmaceutical industry. With the US economy on a growth trajectory, consumer spending on healthcare and medicines is increasing, subsequently bolstering the demand for glass packaging solutions. Moreover, American consumers are increasingly prioritizing sustainable and environmentally friendly packaging. This shift in preference is prompting manufacturers to favor glass ampoules over their plastic counterparts.
- Consumers, legislators, customers, and the media alike are placing heightened emphasis on packaging's environmental attributes. Glass, being the primary choice, is anticipated to propel the growth of the market in the United States. A recent study by the National Retail Federation highlighted that almost 70% of consumers in both the United States and Canada value sustainability and eco-friendliness in brands.
- Many pharmaceutical companies in the United States are set to see enhanced yields from glass ampoules and the introduction of high-speed filling lines. For example, Labiana Pharmaceuticals expanded its manufacturing capabilities by launching a new range of liquid ampoules and investing in state-of-the-art equipment for in-line particle detection. Its expansion features a premium ampoule filling line from Bausch & Strobel, boasting a production capacity of 20,000 ampoules per hour. Additionally, it integrated a Pilastro RS1 final optical inspection machine, designed for in-line production with a throughput of up to 12,000 units per hour.
- The pharmaceutical industry is mainly concerned with the production of pharmaceutical drugs. These drugs diagnose, treat, cure, or prevent various diseases. The pharmaceutical industry is one of the largest in the world, with a global market value of more than USD 1.2 trillion. Top global pharmaceutical companies include Pfizer, Merck, and Johnson & Johnson (all based in the United States). As a result, the pharmaceutical industry in the United States is among the largest in the world.
- Increasing healthcare spending and the government's capital investment in the pharmaceutical packaging market are also major drivers of market growth. According to the US Centers for Medicare and Medicaid Services (CMS), healthcare spending in the United States reached USD 4,799.3 billion in 2023, and it is projected to reach USD 7705 billion by 2032. The ampoules packaging market, driven by technological innovation, growing demand, and strategic collaborations, is well-positioned to experience growth.


North America Ampoules Packaging Industry Overview

The ampoule packaging market in North America is semi-consolidated due to the presence of a few vendors holding significant market shares. The market players are finding new ways, such as strategic partnerships or collaborations, to innovate the development of ampoule packaging in the region, fostering growth.


- October 2023: Glass pioneer SCHOTT unveiled its next-generation type I borosilicate glass tubing, tailored to address the evolving demands of the pharmaceutical industry. This innovative product and its accompanying services align with three pivotal industry trends: the increasing complexity of pharmaceuticals, a commitment to sustainability, and the push toward digitalization. Pharmaceutical converters utilize SCHOTT's glass tubing to manufacture premium vials, ampoules, syringes, and cartridges, adept at storing everything from straightforward medications to intricate, high-complexity drugs.
- March 2023: Bayer AG announced plans to invest USD 1 billion in drug R&D in the United States, aiming to double its US sales by the end of the decade, making it the top pharmaceutical company in the country. According to Sebastian Guth, President of Bayer's pharmaceuticals business in the United States, the company increased the number of US employees working on the marketing of its pharmaceutical business by about 50% over the past three years, which is expected to further increase by about 75% by 2030.


Additional Benefits:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support